Tumor vaccines and beyond

Author： Melenhorst Jan Joseph   Barrett Austin John  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.13, Iss.1, 2011-01, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA-NCI Workshop on Tumor Vaccines

By Przepiorka D  

Cytotherapy, Vol. 1, Iss. 2, 1999-01 ,pp. : 159-159

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy

By Croix B. St.  

Cytotherapy, Vol. 9, Iss. 1, 2007-01 ,pp. : 1-3

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma

By Zhang Hong-Mei   Zhang Li-Wang   Liu Wen-Chao   Cheng Jie   Si Xiao-Ming   Ren Jun  

Cytotherapy, Vol. 8, Iss. 6, 2006-12 ,pp. : 580-588

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Potent in vivo anti-tumor activity of isolated CD62L low lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines

By Liu Z   Fan H   Wu Y   Chen B  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 353-362

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Phyllodes Tumor

By  

Acta Cytologica, Vol. 41, Iss. 2, 2011-09 ,pp. : 321-326

Karger

Access to resources Recommend Favorite